Our Nevisense product line offers cutting-edge solutions for point-of-care skin diagnostics. Designed for clinical accuracy, simplicity and versatility – empowering professionals across dermatology and research.
Nevisense delivers non-invasive skin diagnostics that support early clinical detection and advance dermatological research through objective, reliable data worldwide.
Nevisense opens new possibilities in dermatological research – from barrier assessment to product testing, supporting innovation in both academia and industry.
Nevisense is backed by over three decades of research, clinical experience and a large amount of scientific publications. With 300,000+ patients evaluated worldwide and more than 500 clinics using Nevisense for skin cancer detection, it is a trusted tool for dermatologists, academic researchers and life science companies.
SciBase is a Swedish medtech company driven by a single goal: to improve skin health through smarter diagnostics. With our unique combination of EIS and AI, we lead the way in non-invasive solutions for clinicians and researchers worldwide.
Sign up for the SciBase newsletter to stay up to date with the latest innovations in skin diagnostics, clinical insights and company news. Get expert perspectives, product updates, and research highlights delivered directly to your inbox.
